In:
Journal of Pharmacy Technology, SAGE Publications, Vol. 8, No. 4 ( 1992-07), p. 155-157
Abstract:
To test the clinical usefulness and potency for decreasing plasma calcium concentration of an intravenously administered diphosphonate (aminopropylide diphosphonate [APD]) in a patient with hypercalcemic crisis secondary to primary hyperparathyroidism, unresponsive to hydration and furosemide, and who was ineligible for surgery because of cardiac conduction defects. Design: Case report. Setting: Referred care setting. Intervention: The patient received APD 15 mg/d, dissolved in 100 mL of isotonic NaCl 0.9% and infused in one hour. Main Outcome Measure: Plasma calcium concentration. Results: The patient's plasma calcium concentration fell considerably in a few days. The concomitant decrease in urinary calcium excretion indicates that this fall is caused by a decreased entry of calcium to the extracellular fluid and not to increased renal calcium excretion. After nine days, a parathyroid adenoma was removed; plasma calcium concentration remained normal during the following three years. Conclusions: APD is a useful adjunct to medical therapy in patients with hypercalcemic crisis secondary to primary hyperparathyroidism.
Type of Medium:
Online Resource
ISSN:
8755-1225
,
1549-4810
DOI:
10.1177/875512259200800407
Language:
English
Publisher:
SAGE Publications
Publication Date:
1992
detail.hit.zdb_id:
2411329-3
SSG:
15,3
